Fig. 3

Prevalence of (A) history of cardiovascular disease (CVD), (B) high risk of ASCVD, (C) premature atrial beats, (D) T-wave alterations, and (E) abnormal levels of myocardial enzymes. among patients with hepatocellular carcinoma associated with chronic HBV infection but not MAFLD or chronic HCV infection (“CHB”); HCC associated with MAFLD but not chronic infection with HBV or HCV (“MAFLD”); HCC associated with concurrent MAFLD and chronic HBV infection, but not chronic HCV infection (“CHB/MAFLD”); or HCC associated with chronic HCV infection in the presence or absence of chronic HBV infection and the presence or absence of MAFLD (“HCV”). HBV, hepatitis B virus; HCV, hepatitis C virus; MAFLD, metabolic dysfunction-associated fatty liver disease; ASCVD, arteriosclerotic cardiovascular disease